* CWNM * is our -Red Hot Pharmaceutical Play- for Thursday! Must Read Info Inside…

StockRockandRoll Newsletter

[1]StockRockandRoll.com NEWSLETTER * CWNM * is our -Red Hot Pharmaceutical Play- for Thursday! Must Read Info Inside…

Symbol: [2]CWNM Current PPS: $0.31 Outstanding Shares: 190.1M Float: 67.5M Four Years Ago a Pharmaceutical company that Goes By The Name of Vermillion, Inc. (VRML) Rocketed from 5-Cents to More Than 30-Dollars per Share for an Astounding 60,000% Gain! Every Single Year there are a Few Pharmaceutical Penny Stocks that make Similar Moves…

Could CWNM be the Next Massive Pharmaceutical Winner Crown Marketing (CWNM) is a 2009 founded Pharmaceutical Technology company, based in Chapel Hill, North Carolina that has developed a technological solution for Controlled Drug Delivery.

The Concept of Controlled Drug Delivery is the Time it takes for any Medication to Release within the Body. Current technologies depend heavily on time-release coatings, polymer mesh swelling systems, hydrophilic diffusion matrices, and various other chemical-based delivery methods for the medication to release into the bodys circulation over a period of time. However, the coatings on the pills are only effective when they remain intact; patients are often at risk when a crack or break occurs within the pill. Conversely, Hydrophilic matrices are more effective that the traditional coatings because they are developed from a combinations of stomach acids and fluids to break down the medication in a timely manner. As a result, because no two patients bodies are the same, potential increases of toxicity or decreased bioavailability can occur in different patients even with the most advanced time-release medications. As so, CWNM has [3]Developed a Solution to provide a More Sustained Release of Medication through a Patented Technology Process that Allows for the Potential for a Real-Time 24-Hour Sustained Release Product with consideration given to the Different Intestinal and Gastric Environments. CWNMs Patented Technology is formulated to allow for a broad range of adaption with regards to the mode of administration, dosage form, desired release pattern, and type of compounds employed. CWNMs Technology becomes a Cost Effective Solution as well which will reduce the excess overhead costs of chemical remanufacturing for time release medications and eliminate the risks associated with broken or cracked pill coatings.

Because CWNMs Technology is ideally suited for the Formulation of Prescriptions, Nutraceuticals, and Over-the-Counter Drugs. CWNM recently announced CWNMs Pharmaceutical Technology will be focused on [4]assisting Pharmaceutical Companies in their Lifecycle Management Strategies to extend CWNMs Patent Life for Blockbuster Drugs.

Website(s):

www.crowncddt.com The [5]Global Pharmaceutical Market is expected to reach $1.2 Trillion in 2016; CWNM can aide the Leading Pharmaceutical companies with its State-of-the-Art Time-Released Medication Technology…

According to Research done by [6]CompaniesAndMarkets.com, the Global Nutraceutical Industry is expected to surpass $207 Billion by 2016! The Global Market for Advanced Drug Delivery Systems Totaled More Than $134 Billion in 2008 , and is Projected to Increase to $196 Billion by 2014…

This Rapid Growth Trend comes at a Time where the U.S. Economy has been Struggling as a Whole and Drug Delivery Systems have continued to show Rapid Growth! CWNM is Down Significantly from its 52-Week High of 1-Dollar per Share…

CWNM has been Flying Under the Radar until Today when the Company announced [7]Major News! This Strong News brought Heavy Attention to CWNM leading to a +30% Increase in PPS…

The Upside Potential for CWNM is still Enormous as its Market has Not Been Affected by the Nation`s Down Economy! It could be just a Matter of Time Before we see Pharmaceutical Giants like Pfizer, Merck, and Johnson & Johnson come Knocking On CWNM`s Door…

Currently Trading at just 31-Cents, CWNM looks Extremely Undervalued for a Company with such Rare and Valuable Patented Technology! Pharmaceutical Penny Stocks, in general, have the Highest Probability of Huge Gain Potential in the Shortest Amount of Time…

It is Possible that CWNM could even be the Next VRML-Like Gainer! Members may want to Grab Shares of Thursday`s -Red Hot Pharmaceutical Play- without Delay…

CWNM looks READY to ROCK!! Crown Technology May Allow Multi-Year Patent Extension of Blockbuster Drugs 8:02a ET January 16, 2013 (Market Wire) Crown Marketing (OTCQB: CWNM) is pleased to announce that Crown`s Controlled Drug Delivery Technology (CDDT) will focus on utilizing its unique and novel controlled drug delivery device to assist pharmaceutical companies in their lifecycle management strategies to extend patent life for blockbuster drugs.

With fewer products in the pipeline and blockbuster drugs edging towards the patent cliff, strategies that can extend the commercial life of mature brands are critical to bio-pharmaceutical companies today. Used properly, Lifecycle Management strategies can add several additional years of patent protection and billions of dollars of revenue for mature brands. This is critical in that these are the most profitable years of a brand`s patent life.

Contact:

Charles Van Der Ross 347-491-0565 SOURCE: Crown Marketing ——————————————————————————– —— [8] ——————————————————————————– ————————— Follow SR&R on:

[9][jpeg] [10][jpeg] *To ensure you receive email alerts, please add [11]alerts@stockrockandroll.com to your emails contact list.

——————————————————————————– ————————————————– DISCLAIMER:

This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRockandRoll.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

StockRockandRoll.com does not provide trading, investment or tax advice, and readers shall not rely on statements by StockRockandRoll.com employees which purport to provide such advice. Full disclaimer can be read at http://www.stockrockandroll.com/stock-market-news/disclaimer/

Release of Liability: Through use of this website viewing or using you agree to hold StockRockandRoll.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. StockRockandRoll.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockRockandRoll.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockRockandRoll.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

StockRockandRoll is compliant with the Can Spam Act of 2003.

StockRockandRoll.com does not offer such advice or analysis, and StockRockandRoll.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk.

It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.

StockRockandRoll.com has been compensated Fifteen-thousand dollars for one-day coverage of CWNM by Equities Awareness Group, LLC. StockRockandRoll.com owns NO shares of CWNM, nor intends to buy any in the future. All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1 9 3 3 Securities Act. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. StockRockandRoll.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisement should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact the share price of the profiled company negatively.

StockRockandRoll.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

The Private Securities Litigation Reform Act of 1995 provides investors a `safe harbor` in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”.

Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur.

Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, StockRockandRoll.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, StockRockandRoll.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. StockRockandRoll.com is not responsible for any claims made by the companies advertised herein, nor is StockRockandRoll.com responsible for any other promotional firm, its program or its structure.

——————————————————————————– —————————- StockRockandRoll 2012 HH References 1. http://www.StockRockandRoll.com/

2. http://www.otcmarkets.com/stock/CWNM/company-info 3.

http://finance.yahoo.com/news/crown-marketing-announces-smart-drug-175924186.html 4.

http://finance.yahoo.com/news/crown-technology-may-allow-multi-130100984.html 5.

http://www.nj.com/business/index.ssf/2012/07/for_us_pharmaceutical_industry.html 6. http://Companiesandmarkets.com/

7.

http://finance.yahoo.com/news/crown-technology-may-allow-multi-130100984.html 8. http://www.stockrockandroll.com/welcome 9. https://twitter.com/stockrocknroll 10. http://www.facebook.com/pages/StockRockandRollcom/136235106423119 11. mailto:alerts@stockrockandroll.com This message was sent to from:

MJ Capital, LLC | 800 Main St | Belmar, NJ 07719

Related posts:

1. Pharmaceutical Penny Stocks have Huge Gain Potential; New Pharmaceutical Play on Monday!
2. Breakout Pharmaceutical Play- Could CURX be the Next VRML?
3. CURX-_a_Cure_for_Alzheimer’s_Disease_may_not_be_to_far_
4. ** VIP Early Alert- CWNM is our Extraordinary New Pharmaceutical Epic Pick! **
5. CWNM Latest News Could Change The Pharma Industry For Good – Will You Profit From It?